공시 • Mar 18
PT Asuransi Maximus Graha Persada Tbk, Annual General Meeting, Apr 29, 2026 PT Asuransi Maximus Graha Persada Tbk, Annual General Meeting, Apr 29, 2026. New Risk • Mar 12
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: Rp161.3b (US$9.51m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (50% accrual ratio). Market cap is less than US$10m (Rp161.3b market cap, or US$9.51m). Minor Risk Share price has been volatile over the past 3 months (14% average weekly change). New Risk • Mar 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indonesian stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (50% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Market cap is less than US$100m (Rp206.0b market cap, or US$12.2m). Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to Rp26.00, the stock trades at a trailing P/E ratio of 8.9x. Average trailing P/E is 17x in the Insurance industry in Indonesia. Total loss to shareholders of 64% over the past three years. Valuation Update With 7 Day Price Move • Jan 27
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to Rp36.00, the stock trades at a trailing P/E ratio of 12.3x. Average trailing P/E is 18x in the Insurance industry in Indonesia. Total loss to shareholders of 56% over the past three years. Valuation Update With 7 Day Price Move • Jan 06
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to Rp36.00, the stock trades at a trailing P/E ratio of 12.3x. Average trailing P/E is 16x in the Insurance industry in Indonesia. Total loss to shareholders of 64% over the past three years. Valuation Update With 7 Day Price Move • Dec 01
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to Rp29.00, the stock trades at a trailing P/E ratio of 9.9x. Average trailing P/E is 11x in the Insurance industry in Indonesia. Total loss to shareholders of 75% over the past three years. Board Change • Oct 24
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 4 highly experienced directors. No independent directors (3 non-independent directors). Independent Commissioner Muhamad Idrus was the last independent director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. 공시 • Apr 18
PT Asuransi Maximus Graha Persada Tbk, Annual General Meeting, May 27, 2025 PT Asuransi Maximus Graha Persada Tbk, Annual General Meeting, May 27, 2025. Location: jakarta Indonesia Reported Earnings • Nov 02
Third quarter 2024 earnings released: Rp1.10 loss per share (vs Rp1.43 loss in 3Q 2023) Third quarter 2024 results: Rp1.10 loss per share (improved from Rp1.43 loss in 3Q 2023). Revenue: Rp101.6b (up 24% from 3Q 2023). Net loss: Rp9.84b (loss narrowed 23% from 3Q 2023). Reported Earnings • Aug 03
Second quarter 2024 earnings released: Rp0.38 loss per share (vs Rp4.95 profit in 2Q 2023) Second quarter 2024 results: Rp0.38 loss per share (down from Rp4.95 profit in 2Q 2023). Revenue: Rp92.5b (down 36% from 2Q 2023). Net loss: Rp3.44b (down 108% from profit in 2Q 2023). Valuation Update With 7 Day Price Move • Jul 12
Investor sentiment improves as stock rises 25% After last week's 25% share price gain to Rp10.00, the stock trades at a trailing P/E ratio of 3.9x. Average trailing P/E is 23x in the Insurance industry in Indonesia. Total loss to shareholders of 98% over the past three years. Valuation Update With 7 Day Price Move • Jun 27
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to Rp8.00, the stock trades at a trailing P/E ratio of 3.1x. Average trailing P/E is 22x in the Insurance industry in Indonesia. Total loss to shareholders of 99% over the past three years. Valuation Update With 7 Day Price Move • Jun 05
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to Rp11.00, the stock trades at a trailing P/E ratio of 4.3x. Average trailing P/E is 34x in the Insurance industry in Indonesia. Total loss to shareholders of 98% over the past three years. Valuation Update With 7 Day Price Move • May 15
Investor sentiment improves as stock rises 30% After last week's 30% share price gain to Rp13.00, the stock trades at a trailing P/E ratio of 5.1x. Average trailing P/E is 21x in the Insurance industry in Indonesia. Total loss to shareholders of 98% over the past three years. Valuation Update With 7 Day Price Move • Apr 26
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to Rp13.00, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 27x in the Insurance industry in Indonesia. Total loss to shareholders of 99% over the past three years. Reported Earnings • Apr 24
Full year 2023 earnings released Full year 2023 results: Revenue: Rp393.5b (up 63% from FY 2022). Net income: Rp7.57b (up Rp93.9b from FY 2022). Profit margin: 1.9% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. New Risk • Apr 18
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: Rp152.3b (US$9.44m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 36% per year over the past 5 years. Market cap is less than US$10m (Rp152.3b market cap, or US$9.44m). Minor Risk Share price has been volatile over the past 3 months (9.3% average weekly change). Reported Earnings • Nov 05
Third quarter 2023 earnings released: Rp1.41 loss per share (vs Rp0.34 loss in 3Q 2022) Third quarter 2023 results: Rp1.41 loss per share (further deteriorated from Rp0.34 loss in 3Q 2022). Revenue: Rp100.4b (up 31% from 3Q 2022). Net loss: Rp12.8b (loss widened 317% from 3Q 2022). Reported Earnings • Aug 08
Second quarter 2023 earnings released: EPS: Rp4.95 (vs Rp3.39 loss in 2Q 2022) Second quarter 2023 results: EPS: Rp4.95 (up from Rp3.39 loss in 2Q 2022). Revenue: Rp143.5b (up 183% from 2Q 2022). Net income: Rp44.4b (up Rp74.7b from 2Q 2022). Profit margin: 31% (up from net loss in 2Q 2022). The move to profitability was driven by higher revenue. Reported Earnings • Dec 04
Third quarter 2022 earnings released: Rp0.34 loss per share (vs Rp3.72 profit in 3Q 2021) Third quarter 2022 results: Rp0.34 loss per share (down from Rp3.72 profit in 3Q 2021). Revenue: Rp76.4b (down 29% from 3Q 2021). Net loss: Rp3.06b (down 110% from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 50% per year, which means it is significantly lagging earnings. Board Change • Nov 16
No independent directors There are 4 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 4 new directors. 2 experienced directors. 2 highly experienced directors. No independent directors (3 non-independent directors). Independent Commissioner Hendra Sudjaka is the most experienced director on the board, commencing their role in 2009. Independent Commissioner Muhamad Idrus was the last independent director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors. Reported Earnings • Sep 06
Second quarter 2022 earnings released: Rp3.40 loss per share (vs Rp1.31 profit in 2Q 2021) Second quarter 2022 results: Rp3.40 loss per share (down from Rp1.31 profit in 2Q 2021). Revenue: Rp50.7b (down 15% from 2Q 2021). Net loss: Rp30.4b (down 383% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings. Reported Earnings • Jun 03
Full year 2021 earnings released: EPS: Rp3.34 (vs Rp10.87 loss in FY 2020) Full year 2021 results: EPS: Rp3.34 (up from Rp10.87 loss in FY 2020). Revenue: Rp278.8b (up 66% from FY 2020). Net income: Rp19.6b (up Rp108.1b from FY 2020). Profit margin: 7.0% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has fallen by 44% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Feb 18
Investor sentiment deteriorated over the past week After last week's 18% share price decline to Rp206, the stock trades at a trailing P/E ratio of 52.7x. Average trailing P/E is 18x in the Insurance industry in Indonesia. Total loss to shareholders of 69% over the past three years. Is New 90 Day High Low • Mar 05
New 90-day low: Rp925 The company is down 11% from its price of Rp1,035 on 04 December 2020. The Indonesian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is down 5.0% over the same period. Is New 90 Day High Low • Jan 22
New 90-day low: Rp945 The company is down 10.0% from its price of Rp1,055 on 23 October 2020. The Indonesian market is up 24% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Insurance industry, which is down 16% over the same period. Reported Earnings • Dec 03
Third quarter 2020 earnings released: Rp0.49 loss per share The company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: Rp45.1b (up 15% from 3Q 2019). Net loss: Rp4.04b (loss narrowed 17% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 90% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.